SONOMA PHARMACEUTICALS INC (SNOA) Stock News
NASDAQ:SNOA - Nasdaq - US83558L3033 - Common Stock - Currency: USD
SNOA Latest News, Press Relases and Analysis
Tesla's Texas Plan B if Delaware won’t reinstate Elon Musk's pay. It's not about the money, says Elon.
Texas to the rescue? Tesla is exploring alternative ways to pay its CEO, Elon Musk, in a new deal that, if approved, would be the first time the EV maker’s pay proposal for the world’s richest man would be subject to Texas rather than Delaware law.
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results
Why Sonoma Pharmaceuticals (SNOA) Stock Is Moving
Sonoma Pharmaceuticals shares are trading lower by 7.8% Wednesday morning. The company announced a 1-for-20 reverse stock split.
Fast-paced Momentum Stock Sonoma Pharmaceuticals (SNOA) Is Still Trading at a Bargain
Sonoma Pharmaceuticals (SNOA) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando
More Musk-like 'Dexits' pose fresh threat to Delaware's corporation crown
More CEOs fed up with Delaware and its powerful Chancery Court are going the way of Elon Musk, reincorporating their companies elsewhere and publicly airing their frustrations.